Pyxis Oncology, Inc. Share Price

Pyxis Oncology, Inc. Share Price

PYXS
$2.24
-$0.13 (-5.49%) Last updated on 21 Jul, 2026 | 01:29 IST
  • Performance
  • Chart
  • About
  • Price history
  • FAQs

Pyxis Oncology, Inc. Stock Performance

Open
$2.34
Prev. Close
$2.37
Circuit Range
N/A
Day Range
$2.23 - $2.40
Year Range
$0.97 - $5.55
Volume
16,499
Average Traded
$2.31

Pyxis Oncology, Inc. Share Price Chart

$2.24
Please wait...

About Pyxis Oncology, Inc.

Pyxis Oncology, Inc., a clinical stage company, engages in the development of therapeutics to treat solid tumors. Its lead antibody-drug conjugates (ADC) product candidate is PYX-201, an investigational novel ADC consisting of human immunoglobulin G1 (IgG1), which is in Phase 1 clinical trial to treat patients with relapsed or refractory solid tumors; and lead immuno-oncology (IO) product candidate is PYX-106, an investigational fully human IgG1 Siglec-15-targeting antibody that is in Phase 1 clinical trial to treat patients with advanced solid tumors. The company is also developing PYX-107, a CD40 agonist with demonstrated anti-cancer activity in patients with several cancer indications, which is in Phase 2 clinical trial for the treatment of tumors, such as soft tissue sarcomas, esophageal and gastroesophageal junction, cancers, and pancreatic ductal adenocarcinoma. It has in-license agreement with Pfizer Inc. to develop and commercialize ADC product candidates, including micvotabart pelidotin and PYX-203, and other ADC product candidates directed to the licensed targets; and Biosion USA, Inc. for development, manufacture, and commercialization of PYX-106, an IO product candidate. Pyxis Oncology, Inc. was incorporated in 2018 and is headquartered in Boston, Massachusetts.

Pyxis Oncology, Inc. Historical Data

DayOpenCloseChange %
20-Jul-26
$2.34
$2.24
+0.00%
20-Jul-26
$2.34
$2.24
-5.49%
17-Jul-26
$2.25
$2.37
+6.28%
16-Jul-26
$2.31
$2.23
-8.23%
15-Jul-26
$2.30
$2.43
+6.11%
14-Jul-26
$2.37
$2.29
-5.76%
13-Jul-26
$2.52
$2.43
-9.33%

FAQs on Pyxis Oncology, Inc. Share Price

Can I buy Pyxis Oncology, Inc. shares in India?

chevron-up
Yes. You can buy Pyxis Oncology, Inc. in India by opening an international trading account.

What is the share price of Pyxis Oncology, Inc.?

chevron-up
As on 21 Jul '26, the share price of Pyxis Oncology, Inc. PYXS is $2.24. If you are investing from India, it is a good idea to check the current exchange rate and calculate the value in rupees before making your investment.

What is the 5 year returns of Pyxis Oncology, Inc.?

chevron-up
The 5 year returns of Pyxis Oncology, Inc. is -83.21% as on 21 Jul '26.

What are the high & low stock price of Pyxis Oncology, Inc. today?

chevron-up
Pyxis Oncology, Inc. stock price hit a high of $2.40 and low of $2.23 as on 21 Jul '26.

What is the 52-week high and low of Pyxis Oncology, Inc. stock?

chevron-up
The 52-week high of Pyxis Oncology, Inc. stock is $5.55, while the 52-week low is $0.97 as on 21 Jul '26.